Brummer, Otso
Pölönen, Petri
Mustjoki, Satu http://orcid.org/0000-0002-0816-8241
Brück, Oscar http://orcid.org/0000-0002-7842-9419
Article History
Received: 26 October 2022
Revised: 18 May 2023
Accepted: 14 June 2023
First Online: 30 June 2023
Competing interests
: O Brummer and PP declare no competing financial or non-financial interests. SM declares no competing non-financial interests but the following competing financial interests: research funding from Pfizer, Novartis, Janpix, and Bristol-Myers Squibb, outside the submitted work. O Brück declares no competing non-financial interests but the following competing financial interests: consultancy fees from Novartis, Sanofi, Pfizer, and Amgen, outside the submitted work.
: The study complied with the Declaration of Helsinki. TCGA analyses are permitted based on their ethical statement ExternalRef removed. The Helsinki dataset has been analysed with an approval of the Helsinki University Hospital ethics committee.